Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
Long-term Safety Concerns with Proton Pump Inhibitors
American Journal of Medicine, 09/29/09
Ali T et al. – To provide a comprehensive review regarding the concerns of long–term PPI use, a literature search was performed to identify pertinent original and review articles. Despite study shortcomings, the collective body of information overwhelmingly suggests an increased risk of infectious complications and nutritional deficiencies. Data regarding any increased risk in gastric or colon malignancy are less convincing. PPIs have revolutionized the management and complications of acid–related disorders with a high margin of safety; however, with the data available, efforts to reduce the dosing of or discontinue the use of PPIs must be reassessed frequently.
Related Articles
Teva Receives Final Approval For Generic Prevacid Delayed-Release Capsules
Teva Pharmaceutical Industries, 11/11/09
Relevance Score: 88%
Novartis launches Prevacid24HR over-the-counter for full 24-hour frequent heartburn treatment
Novartis, 11/13/09
Relevance Score: 87%
How Safe Are Popular Reflux Drugs?
MedLinePlus, 11/06/09
Relevance Score: 87%
Consumer Reports Health: Americans With Heartburn Paying Too Much Green For Nexium's 'Purple Pill'
Internet Source, 10/30/09
Relevance Score: 87%
XenoPort Announces Initiation of a Phase 2b Clinical Trial of Arbaclofen Placarbil in Patients with Gastroesophageal Reflux Disease
XenoPort, 10/20/09
Relevance Score: 87%
Today in Stomach/GI...keeping you current
Receive free subspecialty "5-minute updates" via email
A comparison of the acid-inhibitory effects of esomeprazole and pantoprazole in relation to pharmacokinetics and CYP2C19 polymorphism
Alimentary Pharmacology and Therapeutics, 12/10/09
Clinical trial: rebamipide promotes gastric ulcer healing by proton pump inhibitor after endoscopic submucosal dissection
Journal of Gastroenterology, 12/10/09
Repligen Reports Phase 3 Clinical Trial Results of RG1068 in Pancreatic Imaging
Repligen, 12/10/09
Sponsor
Article Search
Sponsor


See Latest Articles


